Cite
HARVARD Citation
Hecht, M. et al. (2020). Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8. Journal for immunotherapy of cancer. 8 (2), p. . [Online].